Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin R Flaherty

Showing results (21-30 of 204) with videos related to

Pageof 21
Sort By:
The New England Journal of Medicine|February 20, 2020
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. ReplyKevin R Flaherty, Athol U Wells, Kevin K Brown
Respirology (Carlton, Vic.)|November 14, 2015
Idiopathic non-specific interstitial pneumoniaElizabeth A Belloli, Rosemarie Beckford, Ryan Hadley, et al.
Respiratory Medicine|October 4, 2016
Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosisSean J Callahan, Meng Xia, Susan Murray, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2022
Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?Vincent Cottin, Kevin K Brown, Kevin R Flaherty, et al.
Expert Opinion on Emerging Drugs|November 3, 2005
Emerging drugs for idiopathic pulmonary fibrosisVictor J Thannickal, Kevin R Flaherty, Robert C Hyzy, et al.
Annals of the American Thoracic Society|February 22, 2024
Use of Race-Specific Equations in Pulmonary Function Tests Impedes Potential Eligibility for Care and Treatment of Pulmonary FibrosisAyodeji Adegunsoye, Wendi Mason Bachman, Kevin R Flaherty, et al.
Chest|January 16, 2003
The solitary pulmonary noduleBethany B Tan, Kevin R Flaherty, Ella A Kazerooni, et al.
Expert Opinion on Pharmacotherapy|July 22, 2004
Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapyVictor J Thannickal, Kevin R Flaherty, Fernando J Martinez, et al.
The European Respiratory Journal|February 16, 2019
Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?Athol U Wells, Kevin K Brown, Kevin R Flaherty, et al.
The European Respiratory Journal|March 20, 2019
Pulmonary fibrosis: "idiopathic" is not "cryptogenic"Athol U Wells, Kevin K Brown, Kevin R Flaherty, et al.
Pageof 21

Showing results (21-30 of 204) with videos related to

Sort By:
Pageof 21
The New England Journal of Medicine|February 20, 2020
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. ReplyKevin R Flaherty, Athol U Wells, Kevin K Brown
Respirology (Carlton, Vic.)|November 14, 2015
Idiopathic non-specific interstitial pneumoniaElizabeth A Belloli, Rosemarie Beckford, Ryan Hadley, et al.
Respiratory Medicine|October 4, 2016
Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosisSean J Callahan, Meng Xia, Susan Murray, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2022
Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?Vincent Cottin, Kevin K Brown, Kevin R Flaherty, et al.
Expert Opinion on Emerging Drugs|November 3, 2005
Emerging drugs for idiopathic pulmonary fibrosisVictor J Thannickal, Kevin R Flaherty, Robert C Hyzy, et al.
Annals of the American Thoracic Society|February 22, 2024
Use of Race-Specific Equations in Pulmonary Function Tests Impedes Potential Eligibility for Care and Treatment of Pulmonary FibrosisAyodeji Adegunsoye, Wendi Mason Bachman, Kevin R Flaherty, et al.
Chest|January 16, 2003
The solitary pulmonary noduleBethany B Tan, Kevin R Flaherty, Ella A Kazerooni, et al.
Expert Opinion on Pharmacotherapy|July 22, 2004
Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapyVictor J Thannickal, Kevin R Flaherty, Fernando J Martinez, et al.
The European Respiratory Journal|February 16, 2019
Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?Athol U Wells, Kevin K Brown, Kevin R Flaherty, et al.
The European Respiratory Journal|March 20, 2019
Pulmonary fibrosis: "idiopathic" is not "cryptogenic"Athol U Wells, Kevin K Brown, Kevin R Flaherty, et al.
Pageof 21